Niguldipine

Star0

DB09239ExperimentalSmall molecule

Niguldipine is a calcium channel blocker drug (CCB) with a1-adrenergic antagonist properties.

Formula / weight: C₃₆H₃₉N₃O₆ · 609.723 g/mol (avg)

Resolves to

Compound

UNIIZ81N45O25ZCAS113165-32-5ChEMBLCHEMBL405355ChEBI103931PubChem60602

Structure

InChIKeySVJMLYUFVDMUHP-XIFFEERXSA-NSMILES[H]N1C(C)=C([C@H](C2=CC(=CC=C2)[N+]([O-])=O)C(C(=O)OCCCN2CCC(CC2)(C2=CC=CC=C2)C2=CC=CC=C2)=C1C)C(=O)OC

Targets

P35368ADRA1BQ13936CACNA1CP25100ADRA1DP35348ADRA1A

Transporters

P08183ABCB1

What you can answer from here — as of August 30, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

1,452Drug interactionsStructured to mechanism, not free text

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Niguldipine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account